Pulmonary hypertension (PH) is known to complicate various forms of interstitial lung
disease (ILD), including idiopathic pulmonary fibrosis, the interstitial pneumonias and …

Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD).
Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in …

Interstitial lung disease (ILD) is a diverse group of inflammatory and fibrotic lung conditions
causing significant morbidity and mortality. A multitude of factors beyond the lungs influence …

Background Pulmonary hypertension (PH) is a common complication of interstitial lung
disease (ILD) and is associated with worse outcomes and increased mortality. Evaluation of …

Interstitial lung disease-associated pulmonary hypertension... : Current Opinion in Pulmonary
Medicine Interstitial lung disease-associated pulmonary hypertension – what the future holds …

Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A
Success, Finally Page 1 pneumonia, particularly among the vulnerable populations that bear a …

Tyvaso DPI is a drug-device combination therapy comprised of a small, portable, reusable,
breath-powered, dry powder inhaler (DPI) for the delivery of treprostinil. It is approved for the …

Objective: Pulmonary hypertension (PH) in context with interstitial lung disease (ILD)
portends serious clinical consequences and a high rate of mortality. Recently published …

Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension
are important and frequently under-recognised conditions. This article provides an overview …

This article aims to summarise the latest research presented at the virtual 2021 European
Respiratory Society (ERS) International Congress in the field of pulmonary vascular disease …